Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medco Plans For Part D Will Be Formed After Election Day

Executive Summary

Medco believes there may be ways to make the private drug insurance model attractive to pharmacy benefit management companies - but does not expect the issue to be resolved until after the elections

You may also be interested in...



Medicare Rx Course Is Clearer Following Bush Victory

President Bush's victory in the Nov. 2 election means that the Centers for Medicare & Medicaid Services will have a chance to create a stand-alone drug insurance program under Medicare

Medicare Rx Course Is Clearer Following Bush Victory

President Bush's victory in the Nov. 2 election means that the Centers for Medicare & Medicaid Services will have a chance to create a stand-alone drug insurance program under Medicare

Medco Hopes For Greater Strategic Freedom, Lower Litigation Risk By 2006

The second anniversary of Medco's spin-off from Merck will give the pharmacy benefit management company additional flexibility to pursue strategic moves in anticipation of the Medicare prescription drug benefit

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044682

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel